explore -WSS

explore

author：focus 2025-10-02 22:24:43 - browse：87

A yellow air ambulance in the sky. -- health business coverage from STAT — Ed Uthman

After Congress officially outlawed surprise medical bills last year, there’s been endless, litigious debate as to how health insurance companies and providers should settle their differences over how much to pay for out-of-network medical bills. Now, an air ambulance provider that already went through the arbitration process is suing Blue Cross Blue Shield of Arizona, which the company says won’t pay the agreed-upon amounts.

The idea behind the arbitration process is to protect patients from getting slapped with massive bills when providers and insurers can’t agree on how much a given health care service is worth. Instead of billing patients for the difference, the government established an independent dispute resolution process in which a third party picks between the provider’s and the payer’s offers for a claim.

This case is one of the first where the provider isn’t disputing the arbitration process itself, or the amount chosen. Instead, the air ambulance company, PHI Health, says BCBS of Arizona has failed to pay up after arbitration — even in cases where the arbitrator chose the amount the insurance company proposed.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： In Spain, a hospital brews its own CAR

focus

knowledge

WSS

SEC charges former device maker CEO with $41 million fraud

WATCH: Why do fingernails fall off when they're damaged?

Drinking less cuts risk of oral cavity, esophageal cancer: Report

In Spain, a hospital brews its own CAR

HCA sued by state AG for quality issues at Mission Health

Violet CEO on training clinicians to promote more inclusive care

focus

explore

focus

Medical records are filled with copy

Gene therapy has helped boys walk. Can scientists keep it that way?

FDA approval of Sarepta Duchenne genetic therapy gives me hope

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Can sheer will power keep patients alive in their dying hours?

Anesthesiologist group: stop taking Ozempic before surgery

CDC concerned about possible undetected monkeypox spread in U.K.

Medicare proposal to cover medical devices draws a mixed reaction

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

hotspot

Violet CEO on training clinicians to promote more inclusive care

What STAT readers think about the FDA and patient advocacy

STAT's guide to the next generation of CAR

Why we need to separate burnout from moral injury in health care

What would happen to your eyes if you looked at the solar eclipse?

Why health care costs have stayed mostly flat since 2010

focus

knowledge

knowledge

leisure time